Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Mr. Richard Paulson$134.6M
Market Cap • 19/04/20242008
(há 16 anos)
2013
(11 years ago)
NASDAQ
Listagem
Newton
Sede • Massachusetts385
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
KPTISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.